it is obvious to me both are in a descending wedge. the question is who is going to bounce. some might say wait for a clear direction coming up. I hope this makes sense to you.
I can't see Vaxart as an already successful bio-tech company with the flu won't be able to enter the realm of the only game in town for an oral vaccination.